Delivery Order SPE2DB22D2007-SPE2DB24FH8LC
Award Date 1/8/24
Potential Completion Date 1/9/24
Potential Value $5.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide OGIVRI 420 MG vials. The contract, valued at $13,116.46, has an ultimate completion date of March 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. This delivery order contract is associated with a larger indefinite delivery contract (IDC) also awarded...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $13,514.50 for the supply of OGIVRI 420 MG VIALS. The contract has an ultimate completion date of June 14, 2024 and was awarded on June 13, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,324.97 firm fixed price contract is for the delivery of 4563372089 OGIVRI 420 MG vials. The contract has a completion date of January 22, 2024 and was awarded on January 19, 2024. There was no set-aside designation used for this award. Amerisourcebergen Drug Corp has...
- This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of OGIVRI 420 MG vials, a pharmaceutical product, to the government. The $9,988.27 firm fixed-price contract was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 4, 2024 and is not designated as a set-aside. The award is likely part of a larger Indefinite Delivery Contract (IDC) held by...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the supply of pharmaceutical products, specifically 4563394938 ! OGSIVEO 50 MG TABLET 180S, with a potential value of $18,704.45. The contract has a completion date of February 7, 2024 and was awarded on January 17, 2024. There is no set-aside designation associated with this contract. Amerisourcebergen Drug...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $15,360.10 by the Defense Logistics Agency (DLA) on January 7, 2026, with an ultimate completion date of January 8, 2026. The contract is for ACT-O-VIALS, a pharmaceutical product delivery, and is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. The place of performance is listed as Conshohocken,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order is for ABRYSVO VIAL WITH DILUENTS, a pharmaceutical product, with a potential value of $21,486.02 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this delivery...
- AmerisourceBergen Drug Corp received a delivery order valued at $4,380.39 from the Defense Logistics Agency (DLA) on January 22, 2026, for the supply of ORGOVYX 120 mg tablets (30-count units). The contract is a firm fixed-price delivery order with an ultimate completion date of February 12, 2026, and was competitively awarded with no set-aside designation. Performance will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for ORGOVYX 120 mg tablets (30-count unit of use packaging) on November 20, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a single transaction under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the delivery of a pharmaceutical product, an "ABRYSVO VIAL WITH DILUENTS", with a potential value of $5,257.44 and a completion date of December 28, 2023. Amerisourcebergen Drug Corp, through its Corporate Office division, provides pharmaceutical products and services to U.S....